MAIDEN
Live / Registered — Registered (as of 13 Dec 2022)
What this means for you
Registered since 13 Dec 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Dec 2028: the §8 declaration of use).
Record
- Serial number
- 90308528
- Registration number
- 6925624
- Mark type
- Word mark
- Filed
- 10 Nov 2020
- Published for opposition
- 24 Aug 2021
- Registered
- 13 Dec 2022
- Next maintenance filing
- §8 declaration of use, due by 13 Dec 2028 (grace period to 13 Jun 2029)
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development services for the discovery of novel patentable chemical molecules; platform as a service (PAAS) featuring computer software technology platform for the discovery of novel patentable chemical molecules
Owner
- Enveda Therapeutics, Inc., Boulder, CO, US
- Enveda Therapeutics, Inc., Boulder, CO, US
- Enveda Therapeutics, Inc., Boulder, CO, US
Prosecution history
- 29 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Dec 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 18 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Dec 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Dec 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Nov 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Oct 2022 — USE AMENDMENT FILED